ACRO BIOMEDICAL changed its Leadership on September 2, 2026, appointing Shao-Hsiang Shih as director and chairman and Jing-Zhou Chen as CEO and CFO. Yu-Ting Su resigned from her director, chairman and CEO roles, effective when a successor was appointed. Investors now have named executives for the company’s principal leadership positions.

Key Highlights

  • Yu-Ting Su’s resignation was not related to any disagreement with ACRO BIOMEDICAL.
  • Shao-Hsiang Shih has worked at Century Publishing Co. since 2010 and became its administrative management director in 2020.
  • Jing-Zhou Chen has led Dream Born Co. Ltd. since March 2025 and previously managed a cloud-kitchen Franchise business.

ACRO BIOMEDICAL CO. LTD. (OTC: ACBM) changed its senior leadership on September 2, 2026, naming Shao-Hsiang Shih chairman and director and Jing-Zhou Chen chief executive officer and chief financial officer. The appointments took effect the same day, while Yu-Ting Su’s departure from the director, chairman and CEO positions became effective when a successor was appointed.

Yu-Ting Su resigned from all three positions without citing any disagreement with ACRO BIOMEDICAL.

Investor Insights

Shih graduated from National Taipei University’s Department of Statistics in 2003 and earned a master’s degree from Fo Guang University’s Graduate Institute of Buddhist Studies in 2018. He has pursued doctoral studies in Eastern Humanistic Thought at Huafan University since 2018.